Yens Purchasing Power Sinks to New Low as Oil Prices Sap Strength Germany and Canada Sign Landmark LNG Agreement Amid Middle East Energy Concerns SpaceX IPO Filing Draws Market Attention KraneShares AGIX Offers Indirect Space Exposure Ferraris First EV Launch Sends Shares Lower as Market Reacts London Tour Operators See Shifting Demand From Landmark Tours to HighSpeed Thames Rides Natural Gas Futures Decline as Weather Forecasts Warm for Early February KMPB Q1 2026 Earnings Significant Earnings Miss Raises Concerns for FixedRate Reset Debentures Jack In The Box Inc JACK Q1 2026 Earnings EPS Miss Weighs on Shares as Restaurant Margins Face Pressure PPC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Circle Internet Group Inc CRCL Q1 2026 Earnings Earnings Beat Fails to Lift Shares Amid Revenue Gap MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain TrustCo Bank TRST Edges Lower Amid Consolidation Near Key Support Levels BRC Group Holdings Senior Notes RILYN Edge Higher to 2486 as Bond Market Calms Sonos SONO Holds Steady Near 1623 as Traders Eye Key Support and Resistance Levels GRAIL Inc GRAL Gains 26 as Shares Approach Key Resistance Level Goosehead Insurance GSHD Falls 48 as Bearish Pressure Intensifies Micron Stock Hits New High as UBS Issues Bullish Price Target on Memory Chip Demand NVVE Q2 2025 Earnings Wide Loss Reported Amidst Operational Challenges Stock Gains 69 GRAIL Inc GRAL Edges Lower Amid Consolidation Near Resistance VOR Q1 2026 Earnings EPS Misses by Substantial Margin Amid Ongoing Pipeline Development Alta Equipment Group Inc ALTG Q1 2026 Earnings EPS Miss Highlights Margin Pressure Amid Mixed Demand GTY Q1 2026 Earnings EPS Surges Past Estimates But Shares Edge Lower Super Group SGHC Q1 2026 Earnings EPS Misses Estimates as Costs Weigh on Results ROP Q1 2026 Earnings Earnings Beat Driven by Strong Execution in Software and Industrial Portfolios MBRX Q1 2026 Earnings Deep EPS Miss Highlights Continued RD Investment Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development